SONN logo

SONN Stock Overview

Profile

Full Name:

Sonnet BioTherapeutics Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 31, 2006

Indexes:

Not included

Description:

Sonnet BioTherapeutics Holdings is a biotechnology company focused on developing innovative therapies for cancer and other diseases. They use a unique platform to create targeted treatments that aim to improve patient outcomes and reduce side effects, making healthcare more effective and accessible.

Key Details

Price

$1.59

Annual Revenue

$18.60 K(-87.42% YoY)

Annual EPS

-$11.35(+92.18% YoY)

Annual ROE

1531.23%

Beta

0.14

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Dec 17, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 30, 2024

Analyst ratings

Recent major analysts updates

Dec 20, 24 Chardan Capital
Buy
Aug 23, 24 Chardan Capital
Buy
May 28, 24 Chardan Capital
Buy
May 16, 24 EF Hutton
Buy
Feb 15, 24 Chardan Capital
Buy
Nov 27, 23 Ladenburg Thalmann
Buy
Aug 16, 23 Chardan Capital
Buy
Jun 26, 23 EF Hutton
Buy
May 11, 23 Chardan Capital
Buy
Apr 19, 23 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Sonnet BioTherapeutics Holdings?
  • Does Sonnet BioTherapeutics Holdings pay dividends?
  • What sector is Sonnet BioTherapeutics Holdings in?
  • What industry is Sonnet BioTherapeutics Holdings in?
  • What country is Sonnet BioTherapeutics Holdings based in?
  • When did Sonnet BioTherapeutics Holdings go public?
  • Is Sonnet BioTherapeutics Holdings in the S&P 500?
  • Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?
  • Is Sonnet BioTherapeutics Holdings in the Dow Jones?
  • When was Sonnet BioTherapeutics Holdings's last earnings report?
  • When does Sonnet BioTherapeutics Holdings report earnings?
  • Should I buy Sonnet BioTherapeutics Holdings stock now?

What is the ticker symbol for Sonnet BioTherapeutics Holdings?

The ticker symbol for Sonnet BioTherapeutics Holdings is NASDAQ:SONN

Does Sonnet BioTherapeutics Holdings pay dividends?

No, Sonnet BioTherapeutics Holdings does not pay dividends

What sector is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Healthcare sector

What industry is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Biotechnology industry

What country is Sonnet BioTherapeutics Holdings based in?

Sonnet BioTherapeutics Holdings is headquartered in United States

When did Sonnet BioTherapeutics Holdings go public?

Sonnet BioTherapeutics Holdings's initial public offering (IPO) was on October 31, 2006

Is Sonnet BioTherapeutics Holdings in the S&P 500?

No, Sonnet BioTherapeutics Holdings is not included in the S&P 500 index

Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?

No, Sonnet BioTherapeutics Holdings is not included in the NASDAQ 100 index

Is Sonnet BioTherapeutics Holdings in the Dow Jones?

No, Sonnet BioTherapeutics Holdings is not included in the Dow Jones index

When was Sonnet BioTherapeutics Holdings's last earnings report?

Sonnet BioTherapeutics Holdings's most recent earnings report was on Feb 13, 2025

When does Sonnet BioTherapeutics Holdings report earnings?

The next expected earnings date for Sonnet BioTherapeutics Holdings is May 14, 2025

Should I buy Sonnet BioTherapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions